Keywords: Bone structure; Obesity; High-fat diet; Ovariectomy; MiceConn.D, connectivity density; CTR, calcitonin receptor; CTSK, cathepsin K; Itgb3, integrin ß3; μCT, micro–computed tomography; RANKL, receptor activator nuclear factor-κB ligand; Sham, sham operated
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: FBGC, foreign body giant cell; MNGC, multinucleated giant cell; HA, hydroxyapatite; CTSK, cathepsin K; TRAP, tartrate-resistant acid phosphatase; MMP, matrix metalloproteinase; RANKL, receptor activator of nuclear factor kappa-B ligand; M-CSF, macrophage
Keywords: ALP, alkaline phosphatase; CTSK, cathepsin K; EF1α, elongation factor 1α; MMP-9, matrix metalloproteinase-9; NaF, sodium fluoride; NFATc1, nuclear factor of activated T-cells and cytoplasmic 1; TRAF6, TNF receptor-associated factor 6; TRAP, tartrate-resis
Effects of 1α,25-(OH)2D3 on the formation and activity of osteoclasts in RAW264.7 cells
Keywords: V-ATPase, vacuolar-type H+-ATPase; CAII, carbonic anhydrase II; CTSK, cathepsin K; TRAP, tartrate-resistant acid phosphatase; MMP-9, matrix metalloproteinase-91α,; 25-(OH)2D3; Osteoclasts; Bone resorption; RANKL; OPG; RAW264.7 cells
Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation
Keywords: SREBP, sterol regulatory element binding protein; RANKL, receptor activator of nuclear factor kappa B ligand; M-CSF, macrophage colony-stimulating factor; TRAP, tartrate-resistant acid phosphatase; CtsK, Cathepsin K; LdlR, low-density lipoprotein receptor
Inhibition of osteoclastogenesis by 6-[10′(Z)-heptadecenyl] salicylic acid from Syzygium tetragonum Wall via preventing nuclear translocation of NFATc1
Keywords: NFATc1, nuclear factor of activated T cells 1; HCS, High Content Screening; TRAP, tartrate-resistant acid phosphatase; MMP9, matrix metalloproteinase 9; CtsK, cathepsin K; RANKL, receptor activator of nuclear factor κB ligand; BMMs, bone marrow derived ma
Mitf regulates osteoclastogenesis by modulating NFATc1 activity
Keywords: Atp6v0d2, vacuolar ATPase Vo domain d2 isoform; BMM, bone marrow macrophages; CsA, cyclosporin A; Ctsk, cathepsin K; DC-STAMP, dendritic cell-specific transmembrane protein; GFP, green fluorescent protein; HA, hemagglutinin; KO, knockout; Mitf, microphtha
A novel mutation (R122Q) in the cathepsin K gene in a Chinese child with Pyknodysostosis
Keywords: CTSK, cathepsin K; OA, osteoarthritis; RA, rheumatoid arthritisPyknodysostosis; Cathepsin K; Missense mutation
Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand
Keywords: RANKL, RL, receptor activator of NFκB ligand; CTSK, cathepsin K; NFATc1, nuclear factor of activated T-cells c1; bp, base pair(s); EMSAs, electrophoretic mobility shift assays; TRAF6, TNF receptor activating factor-6; caNFATc1, constitutively active form
Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB
Keywords: acp5, tartrate-resistant acid phosphatase; bp, base pairs; CAGE, cap analysis gene expression; clcn7, chloride channel 7; CSF-1, macrophage-colony stimulating factor 1; csf1r, colony stimulating factor 1 receptor; ctsk, cathepsin K; cDNA, DNA complementar
AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells
Keywords: AP-1, activator protein-1; bp, base pairs; CTSK, cathepsin K; JNK, jun N-terminal kinase; RANKL, receptor activator of NF-κB ligand; TRAF6, TNF receptor activating factor 6Cathepsin K; RAW 264.7 cells; Osteoclast; Transcription; Nuclear factor; AP-1